FDA Approves First Generic Naloxone Nasal Spray

Drug Industry Daily
The FDA announced full approval of Teva’s generic naloxone nasal spray—tentatively approved last June as the first generic spray for treating opioid overdoses—and said the agency will prioritize reviews of other naloxone generics and push for the development of an over-the-counter version.

To View This Article:


Subscribe To Drug Industry Daily